Despite the promise of SC therapy for AAA treatment (113), a comprehensive and systematic characterization of the elastogenic capabilities of SCs and their effects on the various steps and processes involved in the complex process of elastogenesis (i.e., elastin precursor synthesis, precursor recruitment and cross-linking, and fiber assembly and organization into superstructures) by healthy and diseased SMCs is lacking. This evidence concerns the gene ELN and triple-A syndrome.